Screener
West Pharmaceutical Services WST Debt - Unamortized Discount (Premium) and Issuance Costs, Net
Debt - Unamortized Discount (Premium) and Issuance Costs, Net at other companies
Other financials
Where this comes from
Reported directly by West Pharmaceutical Services in its filing.
Tagged under the XBRL concept us-gaap:UnamortizedDebtIssuanceExpense.
The source filing: West Pharmaceutical Services’s 10-Q, filed July 23, 2026.
- Filed
- Jul 23, 2026, 4:15 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000105770-26-000099
| ($ in millions) | June 30,2026 | December 31,2025 |
|---|---|---|
| Term Loan, due July 2, 2027 (5.08%) | $130.0 | $130.0 |
| Series C notes, due July 5, 2027 (4.02%) | 73.0 | 73.0 |
| 203.0 | 203.0 | |
| Less: unamortized debt issuance costs for Term Loan and Series Notes | 0.1 | 0.2 |
| Total debt | 202.9 | 202.8 |
| Less: current portion of long-term debt | — | — |
| Long-term debt, net | $202.9 | $202.8 |
Item 1. FINANCIAL STATEMENTS (UNAUDITED)
FAQ
- What is West Pharmaceutical Services's debt - unamortized discount (premium) and issuance costs, net?
- West Pharmaceutical Services (WST) reported debt - unamortized discount (premium) and issuance costs, net of $100K in Q2 2026.
- How has West Pharmaceutical Services's debt - unamortized discount (premium) and issuance costs, net changed year-over-year?
- West Pharmaceutical Services's debt - unamortized discount (premium) and issuance costs, net decreased by 75.0% year-over-year, from $400K to $100K.
- What is the long-term trend for West Pharmaceutical Services's debt - unamortized discount (premium) and issuance costs, net?
- Over 5 years (2020 to 2025), West Pharmaceutical Services's debt - unamortized discount (premium) and issuance costs, net has grown at a -16.7% compound annual growth rate (CAGR), from $500K to $200K.
- What does debt - unamortized discount (premium) and issuance costs, net mean?
- This represents the net adjustment to the face value of debt, accounting for original issue discounts, premiums, and capitalized debt issuance costs. These amounts are amortized over the life of the debt instrument to reflect the effective interest rate. It is essential for reconciling the carrying value of debt to its face value.
Ask your AI about West Pharmaceutical Services's debt - unamortized discount (premium) and issuance costs, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude